Mga Batayang Estadistika
| CIK | 1832332 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Aveanna Healthcare Holdings Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 11, 2025 |
other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. |
|
| August 8, 2025 |
FORM 8-K Item 7.01 Regulation FD Disclosure. Item 9.01 Financial Statements and Exhibits. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 08, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (C |
|
| August 8, 2025 |
Investor Presentation August 2025 Investor Presentation August 2025 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healthcare Holdings Inc. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| August 7, 2025 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND REVISED 2025 OUTLOOK Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND REVISED 2025 OUTLOOK • Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year period • Second Quarter Net income was $27.0 million, a 94.3% increase over the prior year period • Adjusted EBITDA for Q2 2025 was $88.4 million, a 93.6% increase over the prior year period • Increased Full Y |
|
| August 7, 2025 |
other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| August 7, 2025 |
Amendment to Amended and Restated Shareholder Agreement dated, June 6, 2025. Exhibit 10.2 AVEANNA HEALTHCARE HOLDINGS INC. AMENDMENT TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT THIS AMENDMENT TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Amendment”), effective as of June 6, 2025 (the “Effective Date”), is made by and among (i) Aveanna Healthcare Holdings Inc., a Delaware corporation (the “Company”), (ii) BCPE Eagle Investor, LP (“Bain Sponsor”), (iii) (a) J.H. W |
|
| June 27, 2025 |
Exhibit 10.1 SEVENTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT This SEVENTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this “Amendment”), dated as of June 25, 2025, is entered into by and among the following parties: (i) AVEANNA SPV I, LLC, as Borrower; (ii) AVEANNA HEALTHCARE LLC, as initial Servicer; (iii) PNC BANK, NATIONAL ASSOCIATION (“PNC”), as Administrative Agent and a Lender |
|
| June 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Com |
|
| June 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 01, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction o |
|
| June 4, 2025 |
AVEANNA HEALTHCARE HOLDINGS COMPLETES ACQUISITION OF THRIVE SKILLED PEDIATRIC CARE Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS COMPLETES ACQUISITION OF THRIVE SKILLED PEDIATRIC CARE Atlanta, Georgia (June 4, 2025) – Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it completed its acquisition of Thrive Skilled Pediatric Care, LLC ("Thrive SPC |
|
| May 23, 2025 |
Aveanna Healthcare Holdings Inc. 52,397,774 Shares of Common Stock As filed pursuant to Rule 424(b)(7) Registration Statement No. 333-281982 Prospectus Supplement (to Prospectus dated September 16, 2024) Aveanna Healthcare Holdings Inc. 52,397,774 Shares of Common Stock This prospectus supplement relates to resales of shares of common stock of Aveanna Healthcare Holdings Inc. by the selling stockholders named herein. The selling stockholders, or the selling stock |
|
| May 9, 2025 |
FORM 8-K Item 7.01 Regulation FD Disclosure. Item 9.01 Financial Statements and Exhibits. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 09, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 9, 2025 |
FORM 8-K Item 5.07 Submission of Matters to a Vote of Security Holders. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 09, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 9, 2025 |
Investor Presentation May 2025 Investor Presentation May 2025 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healthcare Holdings Inc. |
|
| May 8, 2025 |
Exhibit 10.1 Execution Version ELEVENTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT This ELEVENTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT (this “Amendment”), dated as of April 18, 2025, is entered into by Aveanna Healthcare LLC, a Delaware limited liability company (the “Borrower”), the other Credit Parties party hereto, Barclays Bank PLC, as administrative agent (in such capacity, the “Administrati |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Commi |
|
| May 8, 2025 |
other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| May 8, 2025 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND REVISED 2025 OUTLOOK Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND REVISED 2025 OUTLOOK • First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period o Gross margin increased 25.9% to $183.6 million compared to Q1 2024 • First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period o Adjusted Net i |
|
| April 3, 2025 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO ACQUIRE THRIVE SKILLED PEDIATRIC CARE Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO ACQUIRE THRIVE SKILLED PEDIATRIC CARE Atlanta, Georgia (April 3, 2025) – Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Thrive Skilled Pediatric Car |
|
| April 3, 2025 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 01, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| March 25, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
| March 25, 2025 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6 |
|
| March 14, 2025 |
Investor Presentation March 2025 Investor Presentation March 2025 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healthcare Holdings Inc. |
|
| March 14, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| March 13, 2025 |
As filed with the Securities and Exchange Commission on March 13, 2025 As filed with the Securities and Exchange Commission on March 13, 2025 Registration No. |
|
| March 13, 2025 |
Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND 2025 OUTLOOK • Fourth Quarter Revenue was $519.9 million, an 8.6% increase over the prior year period o Gross margin increased 15.7% to $171.7 million compared to Q4 2023 • Fourth Quarter Net income was $29.2 million compared to net loss of $25.7 million for the comparable prior year period o |
|
| March 13, 2025 |
Employment Agreement, dated March 13, 2024 by and among Aveanna Healthcare LLC and Matt Buckhalter Exhibit 10.23 EMPLOYMENT AGREEMENT THIS AGREEMENT is made and entered into on the 1st day of January, 2024 (the “Effective Date”), by and between Aveanna Healthcare Holdings Inc., a Delaware corporation (“Aveanna”); and Matthew Buckhalter, a resident of the State of Georgia (“Executive”). STATEMENT OF BACKGROUND A. Executive has been serving as the Chief Financial Officer of Aveanna and has signif |
|
| March 13, 2025 |
Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Aveanna Healthcare Holdings Inc. (Exact name of registrant as specified in its charter) Table 1 - Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(2) Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Comm |
|
| March 13, 2025 |
Calculation of Filing Fee Tables EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Aveanna Healthcare Holdings Inc. (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(2) Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fe |
|
| March 13, 2025 |
Exhibit 21.1 AVEANNA HEALTHCARE HOLDINGS INC. Subsidiary State or Other Jurisdiction of Formation Name Under Which Subsidiary Does Business 5 Star Home Health Services, LLC Florida Aveanna Home Health AB Innovations Health Services Incorporated Texas Aveanna Healthcare Accredited FMS, Inc. California Aveanna Healthcare Accredited Respite Services, Inc. California Aveanna Healthcare American Staffi |
|
| March 13, 2025 |
Aveanna Securities Trading Policy Exhibit 19.1 AVEANNA HEALTHCARE HOLDINGS INC. SECURITIES TRADING POLICY (Compliance with U.S. Securities Laws and Security Trading) This Securities Trading Policy (this “Policy”) contains the following sections: 1.0 General 2.0 Certain Definitions 3.0 Statement of Policy 4.0 Certain Exceptions 5.0 Window Periods, Pre-clearance of Trades and Other Procedures 6.0 10b5-1 Plans/Margin Accounts and Ple |
|
| March 13, 2025 |
Employment Agreement, dated April 29, 2024, by and among Aveanna Healthcare LLC and Jerry Perchik Exhibit 10.24 EMPLOYMENT AGREEMENT THIS AGREEMENT is made and entered into on the 29th day of April 2024 (the “Effective Date”), by and between Aveanna Healthcare Holdings, Inc., a Delaware corporation, and its subsidiaries (“Aveanna”); and Jerry Perchik, a resident of the State of Georgia (“Executive”). STATEMENT OF BACKGROUND A. Executive has significant experience that will be helpful in managi |
|
| March 13, 2025 |
As filed with the Securities and Exchange Commission on March 13, 2025 As filed with the Securities and Exchange Commission on March 13, 2025 Registration No. |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| March 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition Period from to Commission File Number 001-40362 Aveanna Healthc |
|
| November 8, 2024 |
Investor Presentation November 2024 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Heal |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 08, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| November 7, 2024 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period o Gross margin increased 8.4% to $159.7 million, compared to Q3 2023 • Third Quarter Net loss was $42.8 million, compared to net loss of $102.4 million in the comparable prior year period o Adjusted N |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) ( |
|
| November 7, 2024 |
other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 28, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| November 4, 2024 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES APPOINTMENT OF NEW DIRECTOR Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES APPOINTMENT OF NEW DIRECTOR Atlanta, Georgia (November 4, 2024) – Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Ave |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 01, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| October 4, 2024 |
Exhibit 10.1 Execution Version TENTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT This TENTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT (this “Amendment”), dated as of September 30, 2024, is entered into by Aveanna Healthcare LLC, a Delaware limited liability company (the “Borrower”), the other Credit Parties party hereto, Barclays Bank PLC, as administrative agent (in such capacity, the “Administrative |
|
| October 4, 2024 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO EXTEND ITS REVOLVING CREDIT FACILITY Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO EXTEND ITS REVOLVING CREDIT FACILITY Atlanta, Georgia (October 4, 2024) – Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH), a leading provider of care in the home to pediatric, adult, and geriatric patients, announced that it has amended its First Lien Credit Agreement’s revolving credit facility to extend the revolving cre |
|
| October 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| September 12, 2024 |
Aveanna Healthcare Holdings Inc. 400 Interstate North Parkway SE Suite 1600 Atlanta, GA 30339 Aveanna Healthcare Holdings Inc. 400 Interstate North Parkway SE Suite 1600 Atlanta, GA 30339 September 12, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Juan Grana RE: Aveanna Healthcare Holdings Inc. (the “Company”) Registration Statement on Form S-3 (as amended, the “Registration Statement”) Fil |
|
| September 9, 2024 |
As filed with the Securities and Exchange Commission on September 9, 2024 As filed with the Securities and Exchange Commission on September 9, 2024 Registration No. |
|
| September 6, 2024 |
As filed with the Securities and Exchange Commission on September 6, 2024 Table of Contents As filed with the Securities and Exchange Commission on September 6, 2024 Registration No. |
|
| September 6, 2024 |
Form of Subordinated Indenture Exhibit 4.6 Aveanna Healthcare Holdings Inc. as the Company and [ ] as Trustee Subordinated Indenture Dated as of [ ], [ ] TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 4 Section 1.03. Incorporation by Reference of Trust Indenture Act 4 Section 1.04. Rules of Construction 5 ARTICLE 2 THE SECURITIES Sect |
|
| September 6, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Aveanna Healthcare Holdings Inc. |
|
| September 6, 2024 |
Exhibit 4.5 Aveanna Healthcare Holdings Inc. as the Company and [ ] as Trustee Senior Indenture Dated as of [ ], [ ] TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 3 Section 1.03. Incorporation by Reference of Trust Indenture Act 4 Section 1.04. Rules of Construction 4 ARTICLE 2 THE SECURITIES Section 2. |
|
| August 9, 2024 |
Investor Presentation August 2024 Investor Presentation August 2024 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healthcare Holdings Inc. |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 09, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (C |
|
| August 8, 2024 |
other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| August 8, 2024 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • Second Quarter Revenue was $505.0 million, a 7.0% increase over the prior year o Gross margin increased 1.9% to $158.3 million, compared to Q2 2023 • Second Quarter Net income was $13.9 million, compared to net income of $25.6 million in the comparable prior year period o Adjusted Ne |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| June 5, 2024 |
Exhibit 10.1 EXECUTION VERSION FOURTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT This FOURTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this “Amendment”), dated as of May 31, 2024, is entered into by and among the following parties: (i) AVEANNA SPV I, LLC, as Borrower; (ii) AVEANNA HEALTHCARE LLC, as initial Servicer; (iii) PNC BANK, NATIONAL ASSOCIATION (“PNC”), as Administrative Age |
|
| June 5, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 31, 2024 |
Investor Presentation June 2024 Investor Presentation June 2024 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healthcare Holdings Inc. |
|
| May 17, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 10, 2024 |
Investor Presentation May 2024 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healthcar |
|
| May 10, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 9, 2024 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year o Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 • First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period o Adjusted EBITDA wa |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Commi |
|
| May 9, 2024 |
other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q other a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 14, 2024 |
Claw Back Policy effective as of November 15, 2023 Exhibit 97.1 Aveanna Claw Back Policy Overview General Information 1. Introduction. The Board of Directors (the “Board”) of Aveanna Healthcare Holdings Inc. (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation phil |
|
| March 14, 2024 |
As filed with the Securities and Exchange Commission on March 14, 2024 As filed with the Securities and Exchange Commission on March 14, 2024 Registration No. |
|
| March 14, 2024 |
Exhibit 10.22 EXECUTION VERSION AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (this "Agreement") is made as of December 23, 2016, by and between PEDIATRIC SERVICES OF AMERICA, INC., a Georgia corporation (the "Company"), and Ed Reisz ("Executive"). The "Effective Date" of this Agreement shall be the Closing Date, as such term is defined in that certain Ag |
|
| March 14, 2024 |
Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Aveanna Healthcare Holdings Inc. (Exact name of registrant as specified in its charter) Table 1 - Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(2) Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common |
|
| March 14, 2024 |
Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Aveanna Healthcare Holdings Inc. (Exact name of registrant as specified in its charter) Table 1 - Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(2) Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Comm |
|
| March 14, 2024 |
As filed with the Securities and Exchange Commission on March 14, 2024 As filed with the Securities and Exchange Commission on March 14, 2024 Registration No. |
|
| March 14, 2024 |
Exhibit 21.1 AVEANNA HEALTHCARE HOLDINGS INC. Subsidiary State or Other Jurisdiction of Formation Name Under Which Subsidiary Does Business 5 Star Home Health Services, LLC Florida Aveanna Home Health AB Innovations Health Services Incorporated Texas Aveanna Healthcare Accredited FMS, Inc. California Aveanna Healthcare Accredited Respite Services, Inc. California Aveanna Healthcare American Staffi |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition Period from to Commission File Number 001-40362 Aveanna Healthc |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| March 14, 2024 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER 2023 FINANCIAL RESULTS AND 2024 OUTLOOK Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER 2023 FINANCIAL RESULTS AND 2024 OUTLOOK • Fourth Quarter Revenue was $478.8 million, a 6.1% increase over the prior year o Gross margin increased 15.3% to $148.4 million, compared to Q4 2022 • Fourth Quarter Net loss was $25.7 million, compared to net loss of $237.8 million in the comparable prior year period o Adjusted EBITDA was $ |
|
| February 14, 2024 |
SC 13G 1 ef20021529sc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Aveanna Healthcare Holdings Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 05356F105 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the app |
|
| January 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2024 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) ( |
|
| January 17, 2024 |
Exhibit 10.1 SEPARATION AND TRANSITION AGREEMENT This Separation and Transition Agreement (this “Agreement”) is by and among Shannon Drake (the “Executive”), Aveanna Healthcare LLC (f/k/a BCPE Eagle Buyer LLC) (the “Subsidiary”) and Aveanna Healthcare Holdings Inc., a Delaware corporation (“Holdings,” and together with the Subsidiary, collectively, the “Company”). The Subsidiary, Holdings and the |
|
| December 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| December 11, 2023 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES APPOINTMENT OF CHIEF FINANCIAL OFFICER Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES APPOINTMENT OF CHIEF FINANCIAL OFFICER Atlanta, Georgia (December 11, 2023) – Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| November 14, 2023 |
Investor Presentation November 14, 2023 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna |
|
| November 9, 2023 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS • Revenue was $478.0 million, a 7.9% increase over the prior year o Gross margin increased 9.4% to $147.3 million, compared to Q3 2022 • Net loss was $102.4 million, inclusive of a $105.1 million non-cash goodwill impairment, compared to net income of $24.3 million in the comparable prior year period o Adjusted |
|
| November 9, 2023 |
a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q a UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) ( |
|
| August 10, 2023 |
Execution Version AMENDMENT NO. 1 TO SECOND LIEN CREDIT AGREEMENT This AMENDMENT NO. 1 TO SECOND LIEN CREDIT AGREEMENT (this “Amendment”), dated as of June 30, 2023 (the “Effective Date”), is entered into by Aveanna Healthcare LLC, a Delaware limited liability company (the “Borrower Representative” and a “Borrower”), and Barclays Bank PLC, as administrative agent (in such capacity, the “Administra |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| August 10, 2023 |
Execution Version NINTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT This NINTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT (this “Amendment”), dated as of June 30, 2023 (the “Effective Date”), is entered into by Aveanna Healthcare LLC, a Delaware limited liability company (the “Borrower”), and Barclays Bank PLC, as administrative agent (in such capacity, the “Administrative Agent”). |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (C |
|
| August 10, 2023 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS • Revenue was $471.9 million, a 6.5% increase over the prior year o Gross margin increased 7.0% to $155.3 million, compared to Q2 2022 • Net income was $25.6 million, compared to net loss of $473.9 million in the comparable prior year period o Adjusted EBITDA was $35.8 million, a sequential increase of 25.6% a |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Com |
|
| August 4, 2023 |
EXECUTION VERSION THIRD AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT This THIRD AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this “Amendment”), dated as of July 31, 2023, is entered into by and among the following parties: (i) AVEANNA SPV I, LLC, as Borrower; (ii) AVEANNA HEALTHCARE LLC, as initial Servicer; (iii) PNC BANK, NATIONAL ASSOCIATION (“PNC”), as Administrative Agent and a Lender; and (iv) PNC CAPITAL MARKETS LLC, as Structuring Agent. |
|
| August 4, 2023 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO EXTEND ITS $175 MILLION SECURITIZATION FACILITY Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO EXTEND ITS $175 MILLION SECURITIZATION FACILITY Atlanta, Georgia (August 4, 2023) – Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH), a leading provider of care in the home to pediatric, adults, and geriatric patients, announced that it has amended its securitization facility to extend its maturity to July 31, 2026. The ame |
|
| June 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| June 15, 2023 |
EX-99.1 Exhibit 99.1 Aveanna Announces Resignation of Chief Financial Officer; Announces Corresponding Appointments; Reaffirms FY 2023 Guidance ATLANTA, June 15, 2023 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that David Afshar has resigned from his position as Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer |
|
| May 22, 2023 |
Investor Presentation May 22, 2023 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healt |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 12, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 11, 2023 |
Calculation of Filing Fee Tables EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Aveanna Healthcare Holdings Inc. (Exact name of registrant as specified in its charter) Table 1 - Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(2) Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fe |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 1, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| May 11, 2023 |
Power of Attorney (included on signature pages hereto). As filed with the Securities and Exchange Commission on May 11, 2023 Registration No. |
|
| May 11, 2023 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS • Revenue increased 3.5% to $466.4 million, compared to Q1 2022 o Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022 • Net loss was $32.0 million, compared to net income of $25.3 million in Q1 2022 o Adjusted EBITDA decreased 25.0% to $28.5 million, compared to Q1 2022 • Affirms previously issue |
|
| May 11, 2023 |
Execution Version EIGHTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT EIGHTH AMENDMENT (this “Agreement”), dated as of March 23, 2023, by and among the Revolving Lenders set forth on the signature pages hereto (which constitute the Required Revolving Credit Lenders under the Credit Agreement), the Letter of Credit Issuers set forth on the signature pages hereto (which constitute all of the Letter of Credit Issuers), Aveanna Healthcare LLC, a Delaware limited liability company (the “Borrower”), the other Credit Parties, and Barclays Bank PLC, as the Administrative Agent (the “Administrative Agent”). |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 11, 2023 |
As filed with the Securities and Exchange Commission on May 11, 2023 As filed with the Securities and Exchange Commission on May 11, 2023 Registration No. |
|
| May 11, 2023 |
Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Aveanna Healthcare Holdings Inc. (Exact name of registrant as specified in its charter) Table 1—Newly Registered Securities Security Type Security Class Title Fee Calculation Rule(2) Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common S |
|
| April 26, 2023 |
Ms. Christie Wong and Mr. Brian Cascio April 26, 2023 Ms. Christie Wong and Mr. Brian Cascio Office of Industrial Applications and Services Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549-3561 Re: Aveanna Healthcare Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed March 16, 2023 File No. 001-40362 Dear Ms. Wong and Mr. Cascio: On behalf of Aveanna Healt |
|
| March 31, 2023 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 31, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 17, 2023 |
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 16, 2023 |
DocuSign Envelope ID: F8934D84-8F51-4DAD-B404-4CC929F03FA6 Exhibit 10.27 FINAL SEPARATION AND TRANSITION AGREEMENT This Separation and Transition Agreement (this “Agreement”) is by and among Rodney D. Windley (the “Executive”), Aveanna Healthcare LLC (f/k/a BCPE Eagle Buyer LLC) (the “Subsidiary”) and Aveanna Healthcare Holdings Inc., a Delaware corporation and successor to Pediatric Services of A |
|
| March 16, 2023 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS • Revenue increased 9.0% to $451.1 million, compared to Q4 2021 o Gross margin increased 3.5% to $128.8 million, compared to Q4 2021 • Net loss was $237.8 million, compared to net loss of $126.2 million in Q4 2021 o Adjusted EBITDA decreased 35% to $29.7 million, compared to Q4 2021 Atlanta, Geor |
|
| March 16, 2023 |
DocuSign Envelope ID: F8934D84-8F51-4DAD-B404-4CC929F03FA6 Exhibit 10.26 FINAL SEPARATION AND TRANSITION AGREEMENT This Separation and Transition Agreement (this “Agreement”) is by and among H. Anthony Strange (the “Executive”), Aveanna Healthcare LLC (f/k/a BCPE Eagle Buyer LLC) (the “Subsidiary”) and Aveanna Healthcare Holdings Inc., a Delaware corporation and successor to Pediatric Services of |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2023 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40362 Aveanna Healthc |
|
| March 16, 2023 |
Exhibit 21.1 AVEANNA HEALTHCARE HOLDINGS INC. Subsidiary State or Other Jurisdiction of Formation Name Under Which Subsidiary Does Business 5 Star Home Health Services, LLC Florida Aveanna Home Health AB Innovations Health Services Incorporated Texas Aveanna Healthcare Accredited FMS, Inc. California Aveanna Healthcare Accredited Respite Services, Inc. California Aveanna Healthcare American Staffi |
|
| December 27, 2022 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| December 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of |
|
| December 13, 2022 |
Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES CEO TRANSITION AND REAFFIRMS FY 2022 REVENUE AND ADJUSTED EBITDA GUIDANCE Atlanta, Georgia (December 13, 2022) ? Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that its Chief Executive Officer and Director, To |
|
| December 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2022 (December 7, 2022) Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction |
|
| November 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 1, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) ( |
|
| November 9, 2022 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2022 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2022 FINANCIAL RESULTS Atlanta, Georgia (November 9, 2022) ? Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended October 1, 2022. Tony Stra |
|
| August 11, 2022 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND-QUARTER 2022 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND-QUARTER 2022 FINANCIAL RESULTS Atlanta, Georgia (August 10, 2022) ? Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period ended July 2, 2022. Tony Strange, Chief Ex |
|
| August 11, 2022 |
EXECUTION VERSION Exhibit 10.1 Execution Version SECOND AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT This SECOND AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this ?Amendment?), dated as of August 8, 2022, is entered into by and among the following parties: (i) AVEANNA SPV I, LLC, as Borrower; (ii) AVEANNA HEALTHCARE LLC, as initial Servicer; (iii) PNC BANK, NATIONAL ASSOCIATION (?PNC?), a |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (C |
|
| July 19, 2022 |
Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES PRELIMINARY SECOND QUARTER 2022 RESULTS UPDATED FULL-YEAR 2022 GUIDANCE & EARNINGS RELEASE DATE Atlanta, Georgia (July 19, 2022) ? Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced preliminary second quarter 2022 |
|
| July 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Com |
|
| May 16, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 11, 2022 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST-QUARTER 2022 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST-QUARTER 2022 FINANCIAL RESULTS ? Revenue increased 8.0% to $450.5 million, compared to Q1 2021 ? Acquisitions of Comfort Care (HHH) and Accredited (PDS) drove revenue growth ? Gross margin increased 10.0% to $144.8 million, compared to Q1 2021 ? Net income was $25.3 million, primarily attributable to a $38.3 million non-cash gain on interest |
|
| May 11, 2022 |
insurance UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q insurance UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 2, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| April 27, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| April 27, 2022 |
Investor Presentation April 27, 2022 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation" and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Heal |
|
| March 30, 2022 |
DEFA14A 1 d261567ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| March 30, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 28, 2022 |
Exhibit 21.1 AVEANNA HEALTHCARE HOLDINGS INC. Subsidiary State or Other Jurisdiction of Formation Name Under Which Subsidiary Does Business 5 Star Home Health Services, LLC Florida Aveanna Home Health AB Innovations Health Services Incorporated Texas Aveanna Healthcare Accredited FMS, Inc. California Aveanna Healthcare Accredited Respite Services, Inc. California Aveanna Healthcare American Staffi |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 1, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40362 Aveanna Healthcar |
|
| March 28, 2022 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS ? Fiscal year 2021 revenue increased 12.3% to $1,678.6 million, compared to fiscal year 2020 ? Fiscal year 2021 had 52 weeks compared to 53 weeks in 2020; Q4 2021 had 13 weeks compared to 14 weeks in Q4 2020 ? Net loss was $117.0 million for fiscal year 2021; primarily attributable to a $117.7 mi |
|
| March 28, 2022 |
Exhibit 4.1 Description of Registrant?s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. General As of the end of the period covered by the most recent Annual Report on Form 10-K of Aveanna Healthcare Holdings Inc. (the ?registrant?), the common stock, par value $0.01 per share, of the registrant (?Common Stock?) was registered under Section 12 of the Securities |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2022 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Co |
|
| February 25, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdictio |
|
| February 25, 2022 |
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION References to ?we?, ?us?, ?our?, ?Aveanna? and the ?Company? refer to Aveanna Healthcare Holdings, Inc. |
|
| February 25, 2022 |
COMFORT CARE HOME HEALTH SERVICES, LLC AND SUBSIDIARIES AND AFFILIATES CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS DECEMBER 31, 2020 COMFORT CARE HOME HEALTH SERVICES, LLC AND SUBSIDIARIES AND AFFILIATES TABLE OF CONTENTS DECEMBER 31, 2020 INDEPENDENT AUDITORS? REPORT 1 CONSOLODATED AND COMBINED FINANCIAL STATEMENTS Consolidated and Combined Balance Sheet 3 Consolidated and Combined Statement o |
|
| February 25, 2022 |
COMFORT CARE HOME HEALTH SERVICES, LLC AND SUBSIDIARIES AND AFFILIATES CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 COMFORT CARE HOME HEALTH SERVICES, LLC AND SUBSIDIARIES AND AFFILIATES TABLE OF CONTENTS SEPTEMBER 30, 2021 INDEPENDENT ACCOUNTANTS? REVIEW REPORT 1 CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS Consolidated and Combined Balance Sheet 2 Consolidated and Combined |
|
| February 14, 2022 |
Exhibit A JOINT FILING AGREEMENT In accordance with Rule 13d-1 under the Securities and Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them on a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $. |
|
| February 14, 2022 |
AVAH / Aveanna Healthcare Holdings Inc. / BCPE Eagle Investor, LP - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to ? 240. |
|
| February 14, 2022 |
AVAH / Aveanna Healthcare Holdings Inc. / J.H. Whitney VII, L.P. - SC 13G Passive Investment UNITED STATES SECURITIES & EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Aveanna Healthcare Holdings Inc. (Name of Issuer) Common Stock, $.01 Par Value (Title of Class of Securities) 05356F105 (CUSIP Number) (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| December 16, 2021 |
SECOND LIEN CREDIT AGREEMENT Dated as of December 10, 2021 by and among Aveanna Healthcare Intermediate Holdings LLC, as Holdings, Aveanna Healthcare LLC, as the Borrower Representative, The several Lenders from time to time parties hereto, Barclays Bank PLC, as the Administrative Agent, the Collateral Agent and a Lender, and BARCLAYS BANK PLC, BMO Capital Markets Corp. |
|
| December 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| December 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| November 29, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| November 29, 2021 |
Investor Presentation November 29, 2021 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation" and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna H |
|
| November 15, 2021 |
Investor Presentation November 15, 2021 Exhibit 99.2 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation" and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna H |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| November 15, 2021 |
insurance UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q insurance UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 2, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| November 15, 2021 |
Exhibit 2.2 STOCK PURCHASE AGREEMENT by and between: AVEANNA HEALTHCARE LLC a Delaware limited liability company; and BARRY R. BERGER AND JILL TAFFY STEINFELD-BERGER, TRUSTEES OF THE BARRY R. BERGER AND JILL TAFFY STEINFELD-BERGER FAMILY TRUST DATED SEPTEMBER 19, 2006, and DUNN & BERGER, INC., DBA ACCREDITED NURSING SERVICES, a California corporation And BARRY R. BERGER AND JILL TAFFY STEINFELD-BE |
|
| November 15, 2021 |
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2021 FINANCIAL RESULTS Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD-QUARTER 2021 FINANCIAL RESULTS Third Quarter 2021 Highlights ? Revenue Increased 12.4% to $411.3 Million ? Gross Margin Increased 22.4% to $139.7 Million ? Net Income of $2.1 Million, or $0.01 per Diluted Share ? Adjusted Net Income per Diluted Share of $0.11 ? Adjusted EBITDA Increased 14.6% to $45.8 Million ? Agrees to Acquire Comfort Care |
|
| November 15, 2021 |
Exhibit 10.3 RECEIVABLES FINANCING AGREEMENT Dated as of November 12, 2021 by and among AVEANNA SPV I, LLC, as Borrower, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Lenders, PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent, AVEANNA HEALTHCARE LLC, as initial Servicer, and PNC CAPITAL MARKETS LLC, as Structuring Agent DOCVARIABLE #DNDocID \* MERGEFORMAT 743807286 21689858 ARTICLE I DEFINI |
|
| October 1, 2021 |
Exhibit 2.1 EXECUTION VERSION MEMBERSHIP INTEREST PURCHASE AGREEMENT DATED SEPTEMBER 27, 2021 BY AND AMONG COMFORT CARE HOME HEALTH SERVICES, LLC, (?COMFORT CARE HOME HEALTH?) AND COMFORT CARE HOSPICE, L.L.C. (?COMFORT CARE HOSPICE?) AND PREMIER MEDICAL HOUSECALL, LLC (?PREMIER MEDICAL HOUSECALL?) AND THE SUBSIDIARIES SPECIFIED HEREIN AND THE MEMBERS OF COMFORT CARE HOME HEALTH, COMFORT CARE HOSPI |
|
| October 1, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2021 Aveanna Healthcare Holdings Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) |
|
| August 23, 2021 |
Investor Presentation August 2021 Exhibit 99.1 Disclaimers and Forward-Looking Statements This investor presentation (this "presentation" and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of Aveanna Healthc |
|
| August 23, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (C |
|
| August 11, 2021 |
Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES SECOND-QUARTER 2021 FINANCIAL RESULTS Revenue Increased 24.0% to $436.1 Million Gross Margin Increased 37.5% to $146.6 Million Net Income of $1.3 Million, or $0.01 per Diluted Share Adjusted Net Income per Diluted Share of $0.10 Adjusted EBITDA Increased 30.6% to $48.8 Million Atlanta, Georgia (August 11, 2021) ? Aveanna Healthcare Holdings, Inc. |
|
| August 11, 2021 |
Exhibit 10.5 Execution Version SEVENTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT SEVENTH AMENDMENT (this ?Agreement?), dated as of August 9, 2021, by and among each Revolving Lender set forth on the signature pages hereto, Aveanna Healthcare LLC, a Delaware limited liability company (the ?Borrower?), the other Credit Parties, and Barclays Bank PLC, as the Administrative Agent (the ?Administrative A |
|
| August 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| August 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (C |
|
| July 20, 2021 |
Exhibit 10.1 Execution Version EXTENSION AMENDMENT TO FIRST LIEN CREDIT AGREEMENT dated as of July 15, 2021, among AVEANNA HEALTHCARE INTERMEDIATE HOLDINGS LLC (f/k/a BCPE EAGLE INTERMEDIATE HOLDINGS LLC), as Holdings, AVEANNA HEALTHCARE LLC (f/k/a BCPE EAGLE BUYER LLC), as the Borrower, the Extending Lenders party hereto, and BARCLAYS BANK PLC, as Administrative Agent EXTENSION AMENDMENT TO FIRST |
|
| July 20, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2021 Aveanna Healthcare Holdings Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Com |
|
| July 2, 2021 |
Aveanna Healthcare Holdings Inc. 2021 Employee Stock Purchase Plan. Exhibit 4.3 AVEANNA HEALTHCARE HOLDINGS INC. 2021 EMPLOYEE STOCK PURCHASE PLAN This Aveanna Healthcare Holdings, Inc. 2021 Employee Stock Purchase Plan (the ?Plan?) is effective as of April 28, 2021 (the ?Effective Date?), subject to approval by the Company?s stockholders no later than twelve (12) months after the Effective Date. If stockholder approval is not obtained, then this Plan and any gran |
|
| July 2, 2021 |
As filed with the Securities and Exchange Commission on July 2, 2021 As filed with the Securities and Exchange Commission on July 2, 2021 Registration No. |
|
| July 2, 2021 |
As filed with the Securities and Exchange Commission on July 2, 2021 As filed with the Securities and Exchange Commission on July 2, 2021 Registration No. |
|
| May 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2021 Aveanna Healthcare Holdings Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 25, 2021 |
Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST-QUARTER 2021 FINANCIAL RESULTS Revenue Increased 17.4% to $417.2 Million Gross Margin Increased 22.4% to $131.7 Million Net Income of $5.8 Million, or $0.04 per Diluted Share Adjusted Net Income per Diluted Share of $0.08 Adjusted EBITDA Increased 46.7% to $43.7 Million Atlanta, Georgia (May 25, 2021) ? Aveanna Healthcare Holdings, Inc. (NAS |
|
| May 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40362 Aveanna Healthcare Holdings Inc. |
|
| May 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2021 Aveanna Healthcare Holdings Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Comm |
|
| May 5, 2021 |
Termination of a Material Definitive Agreement, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2021 Aveanna Healthcare Holdings Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40362 81-4717209 (State or Other Jurisdiction of Incorporation) (Commi |
|
| April 30, 2021 |
38,236,000 Shares Aveanna Healthcare Holdings Inc. Common Stock 424B4 1 d63831d424b4.htm 424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-254981 Prospectus 38,236,000 Shares Aveanna Healthcare Holdings Inc. Common Stock This is the initial public offering of shares of common stock of Aveanna Healthcare Holdings Inc. (the “common stock”). We are offering 38,236,000 shares of our common stock. Prior to this offering, there has been n |
|
| April 28, 2021 |
CORRESP 1 filename1.htm Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 BMO Capital Markets Corp. 3 Times Square New York, NY 10036 Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 April 28, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F |
|
| April 28, 2021 |
Prospectus dated April 28, 2021 Table of Contents As filed with the Securities and Exchange Commission on April 28, 2021. |
|
| April 28, 2021 |
AVEANNA HEALTHCARE HOLDINGS INC. 400 Interstate North Parkway S.E. Atlanta, Georgia 30339 AVEANNA HEALTHCARE HOLDINGS INC. 400 Interstate North Parkway S.E. Atlanta, Georgia 30339 April 28, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Attention: Nudrat Salik RE: Aveanna Healthcare Holdings Inc. Registration Statement on Form S-1 (File No. 333-254981) (the ?Registration Statement?) Ladies and Gentlemen: Pursua |
|
| April 26, 2021 |
333 S.E. 2nd Avenue Suite 4100 Miami, Florida 33131 April 26, 2021 Ms. Nudrat Salik Office of Life Sciences Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549-3561 Re: Aveanna Healthcare Holdings, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed April 20, 2021 File No. 333-254981 Dear Ms. Salik: On behalf of our client, Aveanna |
|
| April 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Aveanna Healthcare Holdings Inc. (Exact name of registrant as specified in its charter) Delaware 81-4717209 (State of incorporation or organization) (I.R.S. Employer Identification No.) 400 Interst |
|
| April 26, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on April 26, 2021. |
|
| April 20, 2021 |
Exhibit 21.1 AVEANNA HEALTHCARE HOLDINGS INC. List of Subsidiaries as of March 31, 2021 Subsidiary State or Other Jurisdiction of Formation DBA Name(s) AB Innovations Health Services Incorporated Texas Aveanna Healthcare American Staffing Services, Inc. Pennsylvania Aveanna Healthcare AndVenture, LLC Pennsylvania Aveanna Healthcare Angel?s Touch Home Care, LLC Pennsylvania Aveanna Home Health Assu |
|
| April 20, 2021 |
Exhibit 10.21 AVEANNA HEALTHCARE HOLDINGS INC. 2021 EMPLOYEE STOCK PURCHASE PLAN This Aveanna Healthcare Holdings, Inc. 2021 Employee Stock Purchase Plan (the ?Plan?) is effective as of , 2021 (the ?Effective Date?), subject to approval by the Company?s stockholders no later than twelve (12) months after the Effective Date. If stockholder approval is not obtained, then this Plan and any grants mad |
|
| April 20, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 [?] shares of Common Stock Aveanna Healthcare Holdings Inc. UNDERWRITING AGREEMENT [?], 2021 BARCLAYS CAPITAL INC. J.P. MORGAN SECURITIES LLC BMO CAPITAL MARKETS CORP. CREDIT SUISSE SECURITIES (USA) LLC As Representatives of the several Underwriters named in Schedule I attached hereto, c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 c/o J.P. Morgan Securities LLC |
|
| April 20, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on April 20, 2021. |
|
| April 20, 2021 |
333 S.E. 2nd Avenue Suite 4100 Miami, Florida 33131 April 20, 2021 Ms. Nudrat Salik Office of Life Sciences Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549-3561 Re: Aveanna Healthcare Holdings, Inc. Registration Statement on Form S-1 Filed April 1, 2021 File No. 333-254981 Dear Ms. Salik: On behalf of our client, Aveanna Healthcare Holdings |
|
| April 20, 2021 |
Exhibit 10.20 AVEANNA HEALTHCARE HOLDINGS INC. 2021 STOCK INCENTIVE PLAN 1. Purpose of the Plan. The purpose of this Plan is to advance the interests of the Company?s stockholders by enhancing the Company?s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing such persons with incentive compensation and equity owners |
|
| April 20, 2021 |
Exhibit 3.5 SECOND AMENDED AND RESTATED BYLAWS OF AVEANNA HEALTHCARE HOLDINGS INC. * * * * * ARTICLE I Offices SECTION 1.01 Registered Office. The address of the registered office of Aveanna Healthcare Holdings Inc. (the ?Corporation?) in the State of Delaware is Suite 302, 4001 Kennett Pike, Wilmington, County of New Castle, Delaware 19807. The name of the Corporation?s registered agent at such a |
|
| April 20, 2021 |
Exhibit 3.3 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AVEANNA HEALTHCARE HOLDINGS INC. Aveanna Healthcare Holdings Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (?DGCL?), does hereby certify as follows: (1) The original Certificate of Incorporation of the Corporation was filed with the office of the Secre |
|
| April 20, 2021 |
Exhibit 10.8 AMENDED AND RESTATED AVEANNA HEALTHCARE HOLDINGS INC. 2017 STOCK INCENTIVE PLAN ARTICLE I ESTABLISHMENT AND PURPOSE; ADMINISTRATION 1.1 Establishment. Aveanna Healthcare Holdings Inc., a Delaware corporation (the ?Company?), hereby establishes a stock incentive plan to be known as the ?Aveanna Healthcare Holdings Inc. 2017 Stock Incentive Plan? (the ?Plan?). The Plan became effective |
|
| April 20, 2021 |
Exhibit 10.19 THIRD JOINDER AGREEMENT AND FIFTH AMENDMENT (2021-1 New Revolving Credit Loans) THIRD JOINDER AGREEMENT AND FIFTH AMENDMENT (this ?Agreement?), dated as of March 11, 2021, by and among each New Revolving Loan Lender set forth on the signature pages hereto (each, a ?2021-1 New Revolving Loan Lender?), Aveanna Healthcare LLC, a Delaware limited liability company (the ?Borrower?), the o |
|
| April 20, 2021 |
Exhibit 4.5 AVEANNA HEALTHCARE HOLDINGS INC. AMENDED AND RESTATED STOCKHOLDERS AGREEMENT THIS AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this ?Agreement?) is made as of [ ], 2021 (the ?Effective Date?), by and among (i) Aveanna Healthcare Holdings Inc., a Delaware corporation (the ?Company?), (ii) each of the Sponsors listed on the Schedule of Sponsors attached hereto, as such schedule may be up |
|
| April 20, 2021 |
Exhibit 10.22 INDEMNIFICATION AGREEMENT This Indemnification Agreement (?Agreement?) is made and entered into as of this day of April, 2021, by and among Aveanna Healthcare Holdings Inc., a Delaware corporation (?Parent?), Aveanna Healthcare Intermediate Holdings LLC, a Delaware limited liability company (?Intermediate?) and Aveanna Healthcare LLC, a Delaware limited liability company (?Aveanna? a |
|
| April 20, 2021 |
Exhibit 4.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this ?Agreement?) is made as of [?], 2021 (the ?Effective Date?), by and among (i) Aveanna Healthcare Holdings Inc., a Delaware corporation (the ?Company?), (ii) each of the sponsors listed on the Schedule of Sponsors attached hereto, as such schedule may be updated from time to |
|
| April 20, 2021 |
Exhibit 3.6 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AVEANNA HEALTHCARE HOLDINGS INC. Aveanna Healthcare Holdings Inc., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the ?Corporation?), does hereby certify that: 1. The certificate of incorporation of the Corporation is hereby amended by deleting Section |
|
| April 16, 2021 |
CONFIDENTIAL TREATMENT REQUESTED BY AVEANNA HEALTHCARE HOLDINGS INC. April 16, 2021 FOIA CONFIDENTIAL TREATMENT REQUEST PURSUANT TO 17 C.F.R. ?200.83 The entity requesting confidential treatment is: Aveanna Healthcare Holdings Inc. 400 Interstate North Parkway SE Atlanta, GA 30339 Certain confidential information in this letter has been omitted and provided separately to the Securities and Exchange Commission. Confidential treatment has been requested by Aveanna He |
|
| April 1, 2021 |
Exhibit 10.14 FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT This First Amendment to Amended and Restated Employment Agreement (this ?Amendment?) is made and entered into, effective as of January 23, 2018 (the ?Effective Date?), by and among Aveanna Healthcare LLC f/k/a BCPE Eagle Buyer LLC, a Delaware limited liability company (?Aveanna Healthcare?), Pediatric Services of America, I |
|
| April 1, 2021 |
Exhibit 10.2 FIRST LIEN CREDIT AGREEMENT Dated as of March 16, 2017 By and among BCPE EAGLE INTERMEDIATE HOLDINGS, LLC, as Holdings, BCPE EAGLE BUYER LLC, as the Borrower, The several Lenders from time to time parties hereto, BARCLAYS BANK PLC, as the Administrative Agent, the Collateral Agent, a Letter of Credit Issuer, the Swingline Lender and a Lender, and BARCLAYS BANK PLC, RBC CAPITAL MARKETS |
|
| April 1, 2021 |
Exhibit 10.10 FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT This First Amendment to Amended and Restated Employment Agreement (this ?Amendment?) is made and entered into, effective as of January 23, 2018 (the ?Effective Date?), by and among Aveanna Healthcare LLC f/k/a BCPE Eagle Buyer LLC, a Delaware limited liability company (?Aveanna Healthcare?), Pediatric Services of America, I |
|
| April 1, 2021 |
Exhibit 10.8 AVEANNA HEALTHCARE HOLDINGS INC. 2017 STOCK INCENTIVE PLAN ARTICLE I ESTABLISHMENT AND PURPOSE; ADMINISTRATION 1.1 Establishment. Aveanna Healthcare Holdings Inc., a Delaware corporation (the ?Company?), hereby establishes a stock incentive plan to be known as the ?Aveanna Healthcare Holdings Inc. 2017 Stock Incentive Plan? (the ?Plan?). The Plan shall become effective as of the date |
|
| April 1, 2021 |
Exhibit 10.15 EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is made as of June 29, 2018, by and among AVEANNA HEALTHCARE LLC, a Delaware limited liability company (the ?Company?) and DAVID AFSHAR (?Executive?). The ?Effective Date? of this Agreement shall be February 6, 2018. WHEREAS, the Company seeks to retain Executive?s services pursuant to the terms of this Agreement. NOW, |
|
| April 1, 2021 |
Exhibit 10.11 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (this ?Agreement?) is made as of March 15, 2017, by and among BCPE EAGLE BUYER LLC, a Delaware limited liability company (?Buyer?), PEDIATRIC SERVICES OF AMERICA, INC., a Georgia corporation (the ?Company?), and H. Anthony Strange (?Executive?). The ?Effective Date? of this Agreement shall be the |
|
| April 1, 2021 |
Table of Contents As filed with the Securities and Exchange Commission on April 1, 2021. |
|
| April 1, 2021 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF BCPE EAGLE HOLDINGS INC. * * * * * Christopher Gordon, being the President of BCPE Eagle Holdings Inc., a corporation duly organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY as follows: FIRST: The Corporation filed its original Certificate of Inc |
|
| April 1, 2021 |
Exhibit 10.13 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (this ?Agreement?) is made as of March 15, 2017, by and among BCPE EAGLE BUYER LLC, a Delaware limited liability company (?Buyer?), PEDIATRIC SERVICES OF AMERICA, INC., a Georgia corporation (the ?Company?), and Jeffrey Shaner (?Executive?). The ?Effective Date? of this Agreement shall be the Clo |
|
| April 1, 2021 |
Exhibit 10.12 FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT This First Amendment to Amended and Restated Employment Agreement (this ?Amendment?) is made and entered into, effective as of January 23, 2018 (the ?Effective Date?), by and among Aveanna Healthcare LLC f/k/a BCPE Eagle Buyer LLC, a Delaware limited liability company (?Aveanna Healthcare?), Pediatric Services of America, I |
|
| April 1, 2021 |
Exhibit 4.4 AVEANNA HEALTHCARE HOLDINGS INC. FIRST AMENDMENT TO STOCKHOLDERS AGREEMENT THIS FIRST AMENDMENT TO STOCKHOLDERS AGREEMENT is made as of April 18, 2018 (this ?Amendment?), by and among (i) Aveanna Healthcare Holdings Inc., a Delaware corporation f/k/a BCPE Eagle Holdings Inc. (the ?Company?) and (ii) each of the undersigned Sponsors party hereto (the ?Undersigned Sponsors?). WHEREAS, ea |
|
| April 1, 2021 |
Exhibit 10.17 EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is made as of March 26, 2017, by and among BCPE EAGLE BUYER LLC, a Delaware limited liability company (the ?Company?) and Shannon Drake (?Executive??). The ?Effective Date? of this Agreement shall be , 2017. WHEREAS, the Company seeks to retain Executive?s services pursuant to the terms of this Agreement. NOW, THEREFOR |
|
| April 1, 2021 |
Exhibit 10.5 AMENDMENT NO. 3 TO FIRST LIEN CREDIT AGREEMENT AMENDMENT NO. 3 TO FIRST LIEN CREDIT AGREEMENT (this ?Amendment?), dated as of April 1, 2020, by and among Aveanna Healthcare LLC, a Delaware limited liability company (the ?Borrower?), the other Credit Parties, Barclays Bank PLC, as the Administrative Agent (the ?Administrative Agent?) and each Lender party hereto (constituting Required |
|
| April 1, 2021 |
Exhibit 3.2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF BCPE EAGLE HOLDINGS INC. Pursuant to Section 242 of the General Corporation Law of the State of Delaware BCPE Eagle Holdings Inc. (hereinafter called the ?Corporation?), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify as follows: 1. The amende |
|
| April 1, 2021 |
Exhibit 4.3 BCPE EAGLE HOLDINGS INC. STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this ?Agreement?) is made as of March 16, 2017 (the ?Effective Date?), by and among (i) BCPE Eagle Holdings Inc., a Delaware corporation (the ?Company?), (ii) each of the Sponsors listed on the Schedule of Sponsors attached hereto, as such schedule may be updated from time to time in accordance with the terms |
|
| April 1, 2021 |
Exhibit 3.4 AMENDED AND RESTATED BYLAWS OF BCPE EAGLE HOLDINGS INC. A Delaware Corporation (Adopted as of March 16, 2017) ARTICLE I. OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be located at Suite 302, 4001 Kennett Pike, Wilmington, County of New Castle, Delaware 19807. The name of the registered agent of the Corporation for service |
|
| April 1, 2021 |
Exhibit 10.1 MANAGEMENT AGREEMENT This Management Agreement (this ?Agreement?) is entered into as of March 16, 2017 by and among BCPE Eagle Holdings Inc., a Delaware corporation (?Parent?), BCPE Eagle Intermediate Holdings LLC, a Delaware limited liability company (?Intermediate?), BCPE Eagle Buyer LLC, a Delaware limited liability company (the ?Company?), Bain Capital Private Equity, LP, a Delawa |
|
| April 1, 2021 |
Exhibit 10.7 SECOND LIEN CREDIT AGREEMENT Dated as of March 16, 2017 By and among BCPE EAGLE INTERMEDIATE HOLDINGS, LLC, as Holdings, BCPE EAGLE BUYER LLC, as the Borrower, The several Lenders from time to time parties hereto, ROYAL BANK OF CANADA, as the Administrative Agent, the Collateral Agent and a Lender, and RBC CAPITAL MARKETS*, BARCLAYS BANK PLC, BMO CAPITAL MARKETS CORP., and GOLDMAN SAC |
|
| April 1, 2021 |
333 S.E. 2nd Avenue Suite 4100 Miami, Florida 33131 April 1, 2021 Ms. Nudrat Salik Office of Life Sciences Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549-3561 Re: Aveanna Healthcare Holdings, Inc. Amendment No. 1 to Draft Registration Statement on Form S-1 Submitted February 1, 2021 CIK No. 0001832332 Dear Ms. Salik: On behalf of our clien |
|
| April 1, 2021 |
Exhibit 10.3 JOINDER AGREEMENT AND AMENDMENT (New Term Loans) JOINDER AGREEMENT AND AMENDMENT (this ?Agreement?), dated as of July 1, 2018, by and among each of the New Term Loan Lenders set forth on the signature pages hereto (each, a ?New Term Loan Lender?), Aveanna Healthcare LLC, a Delaware limited liability company (the ?Borrower?), the other Credit Parties, Barclays Bank PLC, as the Administ |
|
| April 1, 2021 |
Exhibit 10.6 SECOND JOINDER AGREEMENT AND FOURTH AMENDMENT (New Term Loans) SECOND JOINDER AGREEMENT AND FOURTH AMENDMENT (this ?Agreement?), dated as of September 21, 2020, by and among the New Term Loan Lender set forth on the signature pages hereto (the ?New Term Loan Lender?), Aveanna Healthcare LLC, a Delaware limited liability company (the ?Borrower?), the other Credit Parties, Barclays Bank |
|
| April 1, 2021 |
Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?) is made as of March 16, 2017 (the ?Effective Date?), by and among (i) BCPE Eagle Holdings, Inc., a Delaware corporation (the ?Company?), (ii) each of the sponsors listed on the Schedule of Sponsors attached hereto, as such schedule may be updated from time to time in accordance with the terms of this Ag |
|
| April 1, 2021 |
Exhibit 10.4 AMENDMENT NO. 2 TO FIRST LIEN CREDIT AGREEMENT AMENDMENT NO. 2 TO FIRST LIEN CREDIT AGREEMENT (this ?Amendment?), dated as of March 19, 2020, by and among Aveanna Healthcare LLC, a Delaware limited liability company (the ?Borrower?), the other Credit Parties, Barclays Bank PLC, as the Administrative Agent (the ?Administrative Agent?) and each Lender party hereto (constituting Required |
|
| April 1, 2021 |
Exhibit 10.18 Amendment to Employment Agreement THIS AMENDMENT TO EMPLOYMENT AGREEMENT is made this 16th day of March, 2020, by and between Aveanna Healthcare LLC, a Delaware limited liability company (the ?company?), and Shannon Drake (?Executive?). WHEREAS, the Company and the Executive are parties to an Employment Agreement dated March 26, 2017 (the ?Employment Agreement?); capitalized terms us |
|
| April 1, 2021 |
Exhibit 10.16 Amendment to Employment Agreement THIS AMENDMENT TO EMPLOYMENT AGREEMENT is made this day of March, 2020, by and between Aveanna Healthcare LLC, a Delaware limited liability company (the ?Company?), and David Afshar (?Executive?). WHEREAS, the Company and the Executive are parties to an Employment Agreement dated February 6, 2018 (the ?Employment Agreement?); capitalized terms used a |
|
| April 1, 2021 |
Exhibit 10.9 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (this ?Agreement?) is made as of March 15, 2017, by and among BCPE EAGLE BUYER LLC, a Delaware limited liability company (?Buyer?), PEDIATRIC SERVICES OF AMERICA, INC., a Georgia corporation (the ?Company?), and Rodney D. Windley (?Executive?). The ?Effective Date? of this Agreement shall be the C |
|
| February 1, 2021 |
Table of Contents Confidential Treatment Requested by Aveanna Healthcare Holdings Inc. |
|
| February 1, 2021 |
333 S.E. 2nd Avenue Suite 4100 Miami, Florida 33131 February 1, 2021 Ms. Nudrat Salik Office of Life Sciences Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549-3561 Re: Aveanna Healthcare Holdings Inc. Draft Registration Statement on Form S-1 Filed December 11, 2020 CIK 0001832332 Dear Ms. Salik: On behalf of our client, Aveanna Healthcare Ho |
|
| December 11, 2020 |
Table of Contents Confidential Treatment Requested by Aveanna Healthcare Holdings Inc. |
